TCTR20160303002Enrolling By Invitation未知
The seroprevalence of neutralizing antibody against Dengue virus in health care workers
Sanofi Pasteur, Thailand0 个研究点目标入组 402 人开始时间: 2016年3月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- Enrolling By Invitation
- 发起方
- 入组人数
- 402
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 21 Years 至 60 Years（—）
- 性别
- All
入选标准
- •Medical personnel who underwent a medical examination in the year 2015 at Queen Sirikit National Institute of Child Health, and voluntarily join the study
排除标准
- •Who did not provided informed consent to a blood test
研究者
相似试验
招募中
不适用
The seroprevalence of neutralizing antibody against Japanese encephalitis virus in health care workersJapanese encephalitis riskJapanese encephalitisSeroprevalenceSeroepidemiologySerological studyBangkokadultshealthcare workersThailandTCTR20151017004Sanofi Pasteur, Thailand400
招募中
不适用
Identification of neutralizing antibodies against severe or chronic infections of human beingDRKS00010169niversitätsklinikum Köln1,000
尚未招募
不适用
Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease SeverityCOVID-19TCTR20210329003King Chulalongkorn Memorial Hospital Excellence Center Program,36
尚未招募
4 期
Antibody persistence at 6 months or more in individuals primed with 2 doses of an inactivated vaccine who received a heterologous or homologous third dose – extension of study RHH_001 and safety and immunogenicity of a 4th dose with recombinant covid-19 vaccine (AstraZeneca/Fiocruz) or mRNA covid-19 vaccine (Comirnaty, Pfizer/ Wyeth)Covid-19C08.730RBR-4b5kzhdInstituto D'Or de Pesquisa e Ensino
进行中（未招募）
4 期
Evaluating the persistence of protection of a 3rd dose of COVID vaccine and the safety and induced protection of a 4th dose of COVID-19 vaccines in previously vaccinated adultsISRCTN12022293niversity of Oxford1,168